Skip to main content

Arrowhead Pharmaceuticals, Inc 10-Q for FY2022 Q1

Arrowhead Pharmaceuticals, Inc. (ARWR)

10-Q 2022-02-02 For: 2021-12-31
View Original
Added on April 08, 2026

About this 10-Q

Arrowhead Pharmaceuticals, Inc filed this 10-Q on February 2, 2022, covering the quarter ended December 31, 2021 (FY2022 Q1).

Headline figures

Quarter ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$27.44M
up 28.8% from $21.3M a year earlier
Net loss
$62.87M
compared with a net loss of $20.73M a year earlier
Diluted EPS
-$0.60
compared with -$0.20 a year earlier